These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24502861)

  • 1. Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression.
    McElroy SL; Keck PE
    J Clin Psychiatry; 2014 Jan; 75(1):46-61. PubMed ID: 24502861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.
    McIntyre RS; Alsuwaidan M; Goldstein BI; Taylor VH; Schaffer A; Beaulieu S; Kemp DE;
    Ann Clin Psychiatry; 2012 Feb; 24(1):69-81. PubMed ID: 22303523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in rates of obesity in bipolar disorder: postulated mechanisms.
    Baskaran A; Cha DS; Powell AM; Jalil D; McIntyre RS
    Bipolar Disord; 2014 Feb; 16(1):83-92. PubMed ID: 24467470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental disorders and metabolic syndrome: a fatamorgana or warning reality?
    Jakovljević M; Crncević Z; Ljubicić D; Babić D; Topić R; Sarić M
    Psychiatr Danub; 2007 Jun; 19(1-2):76-86. PubMed ID: 17603420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
    Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
    Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder.
    Babić D; Maslov B; Martinac M; Nikolić K; Uzun S; Kozumplik O
    Psychiatr Danub; 2010 Mar; 22(1):75-8. PubMed ID: 20305595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and mental illness.
    Newcomer JW
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between bipolar disorder and metabolic syndrome: A review.
    Taylor V; MacQueen G
    J Clin Psychiatry; 2006 Jul; 67(7):1034-41. PubMed ID: 16889445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists.
    Suppes T; McElroy SL; Hirschfeld R
    Psychopharmacol Bull; 2007; 40(2):22-37; quiz 38-40. PubMed ID: 17514184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan.
    Chang HH; Chou CH; Chen PS; Gean PW; Huang HC; Lin CY; Yang YK; Lu RB
    J Affect Disord; 2009 Sep; 117(1-2):124-9. PubMed ID: 19193445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modal subcomponents of metabolic syndrome in patients with bipolar disorder.
    Cardenas J; Frye MA; Marusak SL; Levander EM; Chirichigno JW; Lewis S; Nakelsky S; Hwang S; Mintz J; Altshuler LL
    J Affect Disord; 2008 Feb; 106(1-2):91-7. PubMed ID: 17628693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in bipolar disorder: a review of the literature.
    Michalak EE; Yatham LN; Lam RW
    Health Qual Life Outcomes; 2005 Nov; 3():72. PubMed ID: 16288650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bipolar disorders and metabolic syndrome: implications for primary care.
    Bell PF; McKenna JP; Roscoe BM
    Postgrad Med; 2009 Sep; 121(5):140-4. PubMed ID: 19820282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.
    Basu R; Brar JS; Chengappa KN; John V; Parepally H; Gershon S; Schlicht P; Kupfer DJ
    Bipolar Disord; 2004 Aug; 6(4):314-8. PubMed ID: 15225149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.